These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24374404)

  • 21. Mathematical analysis and optimal control interventions for sex structured syphilis model with three stages of infection and loss of immunity.
    Momoh AA; Bala Y; Washachi DJ; Déthié D
    Adv Differ Equ; 2021; 2021(1):285. PubMed ID: 34131428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmission dynamics and optimal control of a Huanglongbing model with time delay.
    Liao Z; Gao S; Yan S; Zhou G
    Math Biosci Eng; 2021 May; 18(4):4162-4192. PubMed ID: 34198431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Illegal drug users and risk factors for HIV and HCV infection].
    Backmund M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Apr; 50(4):471-5. PubMed ID: 17377722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal control strategies for the transmission risk of COVID-19.
    Lemecha Obsu L; Feyissa Balcha S
    J Biol Dyn; 2020 Dec; 14(1):590-607. PubMed ID: 32696723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dynamic model and some strategies on how to prevent and control hepatitis c in mainland China.
    Jia W; Weng J; Fang C; Li Y
    BMC Infect Dis; 2019 Aug; 19(1):724. PubMed ID: 31420017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C transmission and treatment as prevention - The role of the injecting network.
    Hellard M; McBryde E; Sacks Davis R; Rolls DA; Higgs P; Aitken C; Thompson A; Doyle J; Pattison P; Robins G
    Int J Drug Policy; 2015 Oct; 26(10):958-62. PubMed ID: 26072105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of hepatitis C virus infection in Sweden.
    Duberg A; Janzon R; Bäck E; Ekdahl K; Blaxhult A
    Euro Surveill; 2008 May; 13(21):. PubMed ID: 18761966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unravelling the dynamics of Lassa fever transmission with differential infectivity: Modeling analysis and control strategies.
    Musa SS; Yusuf A; Bakare EA; Abdullahi ZU; Adamu L; Mustapha UT; He D
    Math Biosci Eng; 2022 Sep; 19(12):13114-13136. PubMed ID: 36654038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of a Dengue Model with Vertical Transmission and Application to the 2014 Dengue Outbreak in Guangdong Province, China.
    Zou L; Chen J; Feng X; Ruan S
    Bull Math Biol; 2018 Oct; 80(10):2633-2651. PubMed ID: 30083966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urgent action needed to stop spread of hepatitis B and C in Estonian drug users.
    Tefanova V; Tallo T; Kutsar K; Priimgi L
    Euro Surveill; 2006 Jan; 11(1):E060126.3. PubMed ID: 16801714
    [No Abstract]   [Full Text] [Related]  

  • 31. Bifurcation thresholds and optimal control in transmission dynamics of arboviral diseases.
    Abboubakar H; Kamgang JC; Nkamba LN; Tieudjo D
    J Math Biol; 2018 Jan; 76(1-2):379-427. PubMed ID: 28589490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complex dynamics and control analysis of an epidemic model with non-monotone incidence and saturated treatment.
    Saha P; Ghosh U
    Int J Dyn Control; 2023; 11(1):301-323. PubMed ID: 35637768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global investigation for an "SIS" model for COVID-19 epidemic with asymptomatic infection.
    Alharbi MH
    Math Biosci Eng; 2023 Jan; 20(3):5298-5315. PubMed ID: 36896546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global Analysis and Optimal Control Model of COVID-19.
    Nana-Kyere S; Boateng FA; Jonathan P; Donkor A; Hoggar GK; Titus BD; Kwarteng D; Adu IK
    Comput Math Methods Med; 2022; 2022():9491847. PubMed ID: 35126644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intelligent Network DisRuption Analysis (INDRA): A targeted strategy for efficient interruption of hepatitis C transmissions.
    Campo DS; Khudyakov Y
    Infect Genet Evol; 2018 Sep; 63():204-215. PubMed ID: 29860098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global stability analysis of SEIR model with holling type II incidence function.
    Safi MA; Garba SM
    Comput Math Methods Med; 2012; 2012():826052. PubMed ID: 23091562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium.
    Matheï C; Bourgeois S; Blach S; Brixko C; Mulkay JP; Razavi H; Robaeys G
    Acta Gastroenterol Belg; 2016; 79(2):227-32. PubMed ID: 27382943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal control of HIV/AIDS in the workplace in the presence of careless individuals.
    Seidu B; Makinde OD
    Comput Math Methods Med; 2014; 2014():831506. PubMed ID: 25097663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model for hepatitis C virus transmissions.
    Elbasha EH
    Math Biosci Eng; 2013 Aug; 10(4):1045-65. PubMed ID: 23906202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modifications of epidemiological characteristics of hepatitis C].
    Roudot-Thoraval F
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B138-43. PubMed ID: 12180281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.